Martin J. Duvall is CCO & VP at ARIAD PHARMACEUTICALS INC (ARIA). They have made 4 open-market trades across 2 companies since 2013, most recently 2019-05-28.
CIK 0001313390
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $22K since 2019, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TOCA | BUY | 2019-05-28 | 2019-05-29 | $4.34 | $22K | +14.6% | +48.1% | -20.8% |
| ARIA | SELL · 10b5-1 | 2016-03-19 | 2016-03-22 | $6.47 | $26K | -3.9% | +12.0% | +12.8% |
| ARIA | SELL | 2016-03-03 | 2016-03-03 | $6.12 | $59K | +1.1% | +4.8% | +44.8% |
| ARIA | SELL | 2016-02-01 | 2016-02-03 | $4.81 | $141K | -5.1% | +22.9% | +37.3% |
| ARIA | SELL · 10b5-1 | 2015-09-28 | 2015-09-28 | $6.46 | $32K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2015-07-16 | 2015-07-16 | $8.54 | $12K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2015-03-20 | 2015-03-23 | $8.80 | $43K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2015-02-02 | 2015-02-04 | $6.33 | $93K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL | 2013-03-22 | 2013-03-22 | $19.53 | $11K | -13.2% | +0.2% | +0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.